Kimberly Negrin

Business Unit Leader • Stoic Bio

Dr. Kimberly Negrin is a scientist with an entrepreneurial spirit and passion for building business relationships. She is an accomplished strategy and business operations leader in the cell and gene therapy (CGT) industry. Prior to joining Stoic Bio, Dr. Negrin played a leadership role for HemaCare (a Charles River company) overseeing and supporting clients as they mature through research, clinical, and commercial development of novel engineered and manufactured cell therapy products and applications. She previously worked at Agilent Technologies and Seahorse Bioscience. Dr. Negrin completed her doctoral training at UMass Medical School in the Department of Molecular Medicine, where she earned her Ph.D. in Biomedical Science.

Also Speaking

Tony Ward

Chief Technology Officer • Curate Biosciences

Lisa McClain-Moss

Vice President, Manufacturing • Longeveron

Christian Aguilera-Sandoval

Applications Manager • Accellix

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.